Literature DB >> 17009051

Improving outcomes with radical cystectomy for high-grade invasive bladder cancer.

John P Stein1.   

Abstract

It is clear that the optimal clinical outcomes in bladder cancer patients requiring radical cystectomy are related to standard histopathologic variables of tumor grade, stage and lymph node status. However, other less well defined variables are also critical to the successful outcomes of these patients. Patients with muscle invasive bladder cancer and treating physicians should avoid unnecessary and significant treatment delays. In addition, hospital and surgeon-volume/experience are thought to be factors that may too be important components that relate to the clinical outcomes of patients following surgery. Lastly, there is a growing body of literature to support the concept of an appropriate lymphadenectomy at the time of surgery, for both node-positive and node-negative bladder cancer patients. It is becoming more obvious that there are multiple variables involved in the clinical success and outcomes of patients with bladder cancer following radical cystectomy. As treating physicians and surgeons we must be aware of these components to ensure the best outcomes for our patients.

Entities:  

Mesh:

Year:  2006        PMID: 17009051     DOI: 10.1007/s00345-006-0111-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  40 in total

1.  The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer.

Authors:  P J Barth; E W Gerharz; A Ramaswamy; H Riedmiller
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

2.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

3.  Volume and process of care in high-risk cancer surgery.

Authors:  John D Birkmeyer; Yating Sun; Aaron Goldfaden; Nancy J O Birkmeyer; Therese A Stukel
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

4.  The prognosis with untreated bladder tumors.

Authors:  G R PROUT; V F MARSHALL
Journal:  Cancer       Date:  1956 May-Jun       Impact factor: 6.860

5.  Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy?

Authors:  R E Hautmann; T Paiss
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

6.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

7.  Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy.

Authors:  Christoph Wiesner; Jesco Pfitzenmaier; Andreas Faldum; Rolf Gillitzer; Sebastian W Melchior; Joachim W Thüroff
Journal:  BJU Int       Date:  2005-02       Impact factor: 5.588

8.  Variations in morbidity after radical prostatectomy.

Authors:  Colin B Begg; Elyn R Riedel; Peter B Bach; Michael W Kattan; Deborah Schrag; Joan L Warren; Peter T Scardino
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

9.  Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report.

Authors:  Harry Herr; Cheryl Lee; Sam Chang; Seth Lerner
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

10.  Variation in postoperative complication rates after high-risk surgery in the United States.

Authors:  Justin B Dimick; Peter J Pronovost; John A Cowan; Pamela A Lipsett; James C Stanley; Gilbert R Upchurch
Journal:  Surgery       Date:  2003-10       Impact factor: 3.982

View more
  3 in total

1.  Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in China.

Authors:  Hai Tao Niu; Haitao Niu; Shi Xiu Shao; Shixiu Shao; Zong Liang Zhang; Zongliang Zhang; Shuai Wu; Bo Cheng; De Quan Pang; Dequan Pang; Ya Jun E; Yajun E; Sheng Guo Dong; Shengguo Dong; Guang Sun; Ji Wu Chang; Jiwu Chang
Journal:  Int Urol Nephrol       Date:  2008-09-23       Impact factor: 2.370

2.  The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer.

Authors:  Pantelis Hadjizacharia; John P Stein; Jie Cai; Gus Miranda
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

3.  Vinflunine in the treatment of bladder cancer.

Authors:  Mark Bachner; Maria De Santis
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.